On ECHEMI
Home > Drugs > Transfer factor for injection

Transfer factor for injection

Function and Efficacy

This drug is an immune enhancement drug. It is a polynucleotide peptide (molecular weight less than 5000) extracted from healthy human blood or animal spleen. It is not easily destroyed by RNAse, DNAse and trypsin. This drug is an important factor in cellular immune response. It has no antigenicity and is not an antibody fragment, but it can transmit the cellular immune reactivity of multiple antigens, including bacteria, fungi, viruses, tissue compatibility antigens and tumor-specific antigens, etc. It can enhance the immune reactivity of receptor cells, promote the chemotaxis of macrophages, increase delayed cell response, and improve the body's ability to kill tumors.

Ingredients

The main ingredients of this product are polypeptide and ribose (extracted from pig spleen); the auxiliary material is dextran.

Appearance

This product is a colorless or slightly yellow clear liquid.

Indication

1. Used to treat viral or fungal infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.). 2. Used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.). 3. Used for immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases), and also has a certain therapeutic effect on autoimmune diseases.

Usage and Dosage

Adults: 1. Regular dose. 2. Subcutaneous injection: It is best to inject into the inner side of the upper arm or the lower end of the inner thigh groin where the lymphatic return is rich. It can also be injected subcutaneously into the deltoid muscle of the upper arm, 2-4ml at a time, once a week or two weeks.

Adverse Reactions

1. The most common adverse reactions are pain, nodules and systemic fever at the injection site. Some patients may develop urticaria-like rashes. 2. It has been reported that this drug has caused hemolytic anemia and lymphoma in the treatment of Wiskott-Aldrich Syndrome. 3. It has been reported that this drug can cause typical attacks of bronchial asthma.

Precautions

It is contraindicated for those who are allergic to this product.

Drug Interactions

Not yet clear.

Storage

Sealed and stored in a cool and dark place. Valid for 1.5 years

Packaging Specification

3mg(peptide):100μg(ribose)

Manufacturer

Kunming Longjin Pharmaceutical Co., Ltd.

  • Founded in:

    1996-09-16
  • Address:

    No. 789, Lanmao Road, Majinpu Subdistrict Office, Kunming High-tech Zone, Kunming City, Yunnan Province
  • Tax NO.:

    9153010062260401XJ
  • Registered Funds:

    400.5 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.